3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
2
Lung Neoplasms
2
Urinary Bladder Neoplasms
1
Peripheral Nervous System Diseases
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Gastroesophageal Adenocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma
1
Interventions
Acupuncture Therapy
10
Exercise
7
Cryotherapy
6
Paclitaxel
5
Glutamine
5
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
pembrolizumab
2
enfortumab vedotin
2
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
sagopilone
1
nicotinamide-beta-riboside
1
nabilone
1
glutamic acid diethyl ester
1
allantoicase
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peripheral Nervous System Diseases
×
Single Person
×
Clear all
NCT07629700
2026-06-05
ENDEAVOR
University of Florence
Phase NA
Not yet recruiting
40 enrolled